SCHEMBL469051

SCHEMBL469051

NCc1ccccc1-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 1.00
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 2/20 0.48
HTR7 P34969 1/20 0.47
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
PNMT P11086 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CSNK2A1 P68400 2/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
FOLH1 Q04609 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
HPGD P15428 1/20 0.42
BCL2L1 Q07817 1/20 0.42
CYP2A6 P11509 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29872374 1.00 DPP4 (1.00) DPP4KMT2AALDH1A1HSD17B10HTR7
Hydrochloric Acid SCHEMBL4776720 0.98 DPP4 (0.95) DPP4KMT2AALDH1A1HSD17B10HTR7
SCHEMBL2981250 0.95 DPP4 (0.91) DPP4KMT2AALDH1A1HSD17B10HTR7
Bicarbonate SCHEMBL27817695 0.91 DPP4 (0.83) DPP4KMT2AALDH1A1HSD17B10HTR7
SCHEMBL27670027 0.91 DPP4 (0.83) DPP4KMT2AALDH1A1HSD17B10HTR7
Formamide SCHEMBL28864488 0.89 DPP4 (0.80) DPP4KMT2AALDH1A1HSD17B10HTR7
Hydrogen Sulfide SCHEMBL27639875 0.89 DPP4 (0.79) DPP4KMT2AALDH1A1HSD17B10HTR7
Hydrochloric Acid SCHEMBL29502692 0.89 DPP4 (0.79) DPP4KMT2AALDH1A1HSD17B10HTR7
SCHEMBL399409 0.84 DPP4 (0.72) DPP4KMT2AALDH1A1HSD17B10PNMT
SCHEMBL3789431 0.84 DPP4 (0.72) DPP4CD274PNMTTAAR1CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4685176-A1 2-COMPONENT FOAMS BASED ON ACETYLACETONATE AND AMINES Henkel AG & Co. KGaA (DE) 2026-01-28 EP claimed
CN-115282782-B Total heat exchange membrane doped with functionalized ZIF-7 nanoparticles and preparation method thereof 浙江工业大学 2025-01-28 CN claimed
CN-115487693-B Polyamide/polyolefin mixed matrix nanofiltration membrane and preparation method thereof 浙江工业大学 2024-10-11 CN claimed
CN-117551410-A Non-conductive adhesive, preparation method and application thereof, flexible wearable device and preparation method thereof 深圳先进电子材料国际创新研究院 2024-02-13 CN claimed
CN-114849473-B Secondary polymerization synchronous self-sealing ZIF-8 modified reverse osmosis membrane and preparation method thereof 浙江工业大学 2023-09-05 CN claimed
CN-116392976-A In-situ etched ZIF nanoparticle modified reverse osmosis membrane and preparation method thereof 浙江工业大学 2023-07-07 CN claimed
CN-116020265-A Hollow ZIFs modified high-flux reverse osmosis membrane and preparation method thereof 浙江工业大学 2023-04-28 CN claimed
CN-115487693-A Polyamide/polyolefin mixed matrix nanofiltration membrane and preparation method thereof 浙江工业大学 2022-12-20 CN claimed
CN-115382394-A Polyolefin-based composite nanofiltration membrane modified by UIO-66 nano material and preparation method thereof 浙江工业大学 2022-11-25 CN claimed
CN-115282782-A Total heat exchange membrane doped with functionalized ZIF-7 nanoparticles and preparation method thereof 浙江工业大学 2022-11-04 CN claimed
WO-2003095445-A1 NEW ORGANIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME LG CHEM, LTD. (KR) 2003-11-20 WO claimed
US-20030004172-A1 Fused pyrimidinone matrix metalloproteinase inhibitors HARTER WILLIAM GLEN (US) 2003-01-02 US claimed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO claimed
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 EP claimed
EP-0606858-B1 Liquid crystal compositions and liquid crystal display devices CHISSO CORP (JP) 2000-04-26 EP claimed
EP-0787766-B1 Ambient vulcanising silicone rubbers crosslinking by condensation mechanism WACKER CHEMIE GMBH (DE) 1999-08-04 EP claimed
WO-1999031124-A1 CHOLIC ACID-BASED SCAFFOLDS FOR MULTIDIMENSIONAL MOLECULAR PRESENTATION OF PEPTIDES NOVO NORDISK A/S (DK) 1999-06-24 WO claimed
EP-0787766-A1 Ambient vulcanising silicone rubbers crosslinking by condensation mechanism Wacker-Chemie GmbH (DE) 1997-08-06 EP claimed
EP-0512950-B1 Substituted 1-aminonaphtalenes and stabilized compositions CIBA GEIGY AG (CH) 1996-01-17 EP claimed
EP-0010160-A1 Plaquette for the dosimetry of reactive gases BAYER AG (DE) 1980-04-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004172-A1 Fused pyrimidinone matrix metalloproteinase inhibitors MMP13, MMP3, MMP25 DPP4 355/4885KMT2A 1976/4885ALDH1A1 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.